Search Results

• • 857 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Molecular mechanism of alcoholic fatty liver

  Authors:Karuna Rasineni and Carol CaseyFrom:Indian Journal of Pharmacology (Vol. 44, Issue 3) Peer-Reviewed

  May-June 20124,002 words Report 1850LByline: Karuna. Rasineni, Carol. Casey Ethanol abuse and chronic ethanol consumption remains a major public health problem and is responsible for a high rate of morbidity. Alcohol-induced fatty liver generally begins...

• Study of fatty liver syndrome frequency in dairy cattle by evaluating NEFA, APO-A, Ammoniac, Tsh and Total Bilirobin serum values in Tabriz

  Authors:Amirparviz Rezaeisaber and Mehrdad NazeriFrom:Advances in Environmental BiologyPeer-Reviewed

  June 20112,396 words Report 1530LFatty liver syndrome (Hepatic lipidosis) or fat cow syndrome is a major metabolic disorder in many dairy cattle's in early period of lactation. The aim of this study was to evaluating fatty liver syndrome in dairy...

• Association of the components of the metabolic syndrome with non- alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents

  Authors:Roya Kelishadi, Stephen R. Cook, Atoosa Adibi, Zahra Faghihimani, Shohreh Ghatrehsamani, Abolfazl Beihaghi, et al.From:Diabetology & Metabolic Syndrome (Vol. 1) Peer-Reviewed

  Dec. 22, 20094,679 words Report Authors: Roya Kelishadi (corresponding author) [1]; Stephen R Cook [2]; Atoosa Adibi [3]; Zahra Faghihimani [4]; Shohreh Ghatrehsamani [4]; Abolfazl Beihaghi [5]; Hamidreza Salehi [5]; Noushin Khavarian [4]; Parinaz...

• Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease

  Authors:Isabel VA Pereira, Jose T Stefano, and Claudia PMS OliveiraFrom:Expert Review of Gastroenterology & Hepatology (Vol. 5, Issue 2) Peer-Reviewed

  Apr. 20115,708 words Article 1430LAuthor(s): Isabel VA Pereira 1 , José T Stefano 1 , Cláudia PMS Oliveira [[dagger]] 2 Keywords : microsomal triglyceride transfer protein; MTP; NASH; nonalcoholic fatty liver disease; steatosis Nonalcoholic...

• Correction: Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

  From:PLoS ONE (Vol. 9, Issue 3) Peer-Reviewed

  Mar. 10, 2014129 words Brief article, Corre... 830LAuthor(s): The PLOS ONE Staff An affiliation for the sixth author is incorrect, and an affiliation for the sixth author is missing. Stefania Boccia is affiliated with the following institutions: Section of Hygiene,...

• Traditional but Not HIV-Related Factors Are Associated with Nonalcoholic Fatty Liver Disease in Asian Patients with HIV-1 Infection

  Authors:Takeshi Nishijima, Hiroyuki Gatanaga, Takuro Shimbo, Hirokazu Komatsu, Yuichi Nozaki, Naoyoshi Nagata, et al.From:PLoS ONE (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 31, 20143,617 words Article 1490LAuthor(s): Takeshi Nishijima 1,4, Hiroyuki Gatanaga 1,4,*, Takuro Shimbo 3, Hirokazu Komatsu 5, Yuichi Nozaki 2, Naoyoshi Nagata 2, Yoshimi Kikuchi 1, Mikio Yanase 2, Shinichi Oka 1,4 Introduction Nonalcoholic...

• Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability

  Authors:Yu-Chen Liu, Chi-Sheng Hung, Yen-Wen Wu, Yi-Chin Lee, Yen-Hung Lin, Chen Lin, et al.From:PLoS ONE (Vol. 8, Issue 4) Peer-Reviewed

  Apr. 23, 20134,428 words Article 1820LAuthor(s): Yu-Chen Liu 1,2, Chi-Sheng Hung 1, Yen-Wen Wu 2,3,4,5, Yi-Chin Lee 6, Yen-Hung Lin 1, Chen Lin 7,8, Men-Tzung Lo 7,8, Chun-Chieh Chan 9, Hsi-Pin Ma 9, Yi-Lwun Ho 1,*, Chien-Hung Chen 10 Introduction...

• Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers

  Authors:Takahisa Kawaguchi, Toshihide Shima, Masayuki Mizuno, Yasuhide Mitsumoto, Atsushi Umemura, Yoshihiro Kanbara, et al.From:PLoS ONE (Vol. 13, Issue 1) Peer-Reviewed

  Jan. 31, 20185,877 words Report 1440LAuthor(s): Takahisa Kawaguchi 1, Toshihide Shima 2, Masayuki Mizuno 2, Yasuhide Mitsumoto 2, Atsushi Umemura 2, Yoshihiro Kanbara 3, Saiyu Tanaka 4, Yoshio Sumida 4, Kohichiro Yasui 5, Meiko Takahashi 1, Keitaro Matsuo...

• Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease

  Authors:Peter R. Baker, II and Jacob E. FriedmanFrom:Journal of Clinical Investigation (Vol. 128, Issue 9) Peer-Reviewed

  Sept. 201810,767 words Report 1410LNonalcoholic fatty liver disease (NAFLD) is a global epidemic in obese children and adults, and the onset might have fetal origins. A growing body of evidence supports the role of developmental programming, whereby the...

• Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition

  Authors:Hu Huang, Seung-Hwan Lee, Ines Sousa-Lima, Sang Soo Kim, Won Min Hwang, Yossi Dagon, et al.From:Journal of Clinical Investigation (Vol. 128, Issue 12) Peer-Reviewed

  Dec. 201810,535 words Report 1430LObesity is a major risk factor for developing nonalcoholic fatty liver disease (NAFLD). NAFLD is the most common form of chronic liver disease and is closely associated with insulin resistance, ultimately leading to...

• Noninvasive quantification of liver fat content by different gradient echo magnetic resonance imaging sequences in patients with nonalcoholic fatty liver disease

  Authors:Mansour Zabihzadeh, Mohammad Gharibvand, Azim Motamedfar, Morteza Tahmasebi, Amir Sina, Kavous Bahrami, et al.From:Journal of Medical Signals & Sensors (Vol. 8, Issue 4) Peer-Reviewed

  October-December 20183,789 words Clinical report 1590LByline: Mansour. Zabihzadeh, Mohammad. Gharibvand, Azim. Motamedfar, Morteza. Tahmasebi, Amir. Sina, Kavous. Bahrami, Mozafar. Naserpour Background: Noninvasive quantification of liver fat by gradient echo (GRE)...

• Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

  Authors:Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, et al.From:International Journal of Hepatology (Vol. 2018) Peer-Reviewed

  Annual 20185,038 words Article 1460LBackgrounds. The aim of this study was to appraise the relationship between serum fragmented cytokeratin-18(CK-18), controlled attenuation parameter (CAP), and liver steatosis assessed by ultrasound (US) in nonalcoholic...

• Rise in adolescent NAFLD outpacing obesity

  Author:Diana MahoneyFrom:Family Practice News (Vol. 42, Issue 10)

  June 1, 2012524 words Article 1500LObese children have gotten fatter around the middle over time, a development that may account in part for an observed increase in suspected nonalcoholic fatty liver disease among adolescents. Nonalcoholic fatty liver...

• Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.

  Authors:Robert N Helsley, Venkateshwari Varadharajan, Amanda L Brown, Anthony D Gromovsky, Rebecca C Schugar, Iyappan Ramachandiran, et al.From:eLife (Vol. 8) Peer-Reviewed

  Oct. 17, 201925,744 words Article 1500LRecent studies have identified a genetic variant rs641738 near two genes encoding membrane bound O-acyltransferase domain-containing 7 (MBOAT7) and transmembrane channel-like 4 (TMC4) that associate with increased risk...

• Nonalcoholic fatty liver disease and hepatocellular carcinoma

  Authors:Luciana Kikuchi, Claudia P. Oliveira, and Flair J. CarrilhoFrom:BioMed Research InternationalPeer-Reviewed

  Annual 20144,084 words Report 1320LHepatocellular carcinoma (HCC) incidence is increasing worldwide in recent years. Most HCC cases develop in the presence of advanced chronic liver disease related to chronic hepatitis C virus (HCV) infection, chronic...

• Crude extracts from Lycium barbarum suppress SREBP-1c expression and prevent diet-induced fatty liver through AMPK activation

  Authors:Wang Li, Yan Li, Qing Wang, and Yi YangFrom:BioMed Research InternationalPeer-Reviewed

  Annual 20144,148 words Report 1330LLycium barbarum polysaccharide (LBP) is well known in traditional Chinese herbal medicine that, has beneficial effects. Previous study reported that LBP reduced blood glucose and serum lipids. However, the underlying...

• Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study

  Authors:Ina-Maria Ruckert, Margit Heier, Wolfgang Rathmann, Sebastian E. Baumeister, Angela Doring, and Christa MeisingerFrom:PLoS ONE (Vol. 6, Issue 8) Peer-Reviewed

  Aug. 5, 20116,531 words Article 1550LObjective To investigate whether the elevated liver enzymes gamma-glutamyltransferase (GGT), glutamate-pyruvate transaminase (GPT), glutamate-oxalacetate transaminase (GOT) and alkaline phosphatase (AP) and...

• Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease

  Authors:Sulin Cheng, Petri Wiklund, Reija Autio, Ronald Borra, Xiaowei Ojanen, Leiting Xu, et al.From:PLoS ONE (Vol. 10, Issue 10) Peer-Reviewed

  Oct. 6, 20158,210 words Report 1430LBackground Fatty liver is a major cause of obesity-related morbidity and mortality. The aim of this study was to identify early metabolic alterations associated with liver fat accumulation in 50- to 55-year-old men...

• Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass

  Authors:Birgit Knebel, Jutta Haas, Sonja Hartwig, Sylvia Jacob, Cornelia Kollmer, Ulrike Nitzgen, et al.From:PLoS ONE (Vol. 7, Issue 2) Peer-Reviewed

  Feb. 21, 20128,367 words Article 1430LThe pathogenesis of fatty liver is not understood in detail, but lipid overflow as well as de novo lipogenesis (DNL) seem to be the key points of hepatocyte accumulation of lipids. One key transcription factor in DNL is...

• Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

  Authors:Xi-Xi He, Xiao-Li Wu, Ren-Pin Chen, Chao Chen, Xiao-Gang Liu, Bin-Jiao Wu, et al.From:PLoS ONE (Vol. 11, Issue 10) Peer-Reviewed

  Oct. 6, 20166,592 words Article 1370LBackground Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome with the main characteristic of diffuse liver cells with fatty changes. The clinical evolution of NAFLD includes simple non-alcoholic fatty...